A minoxidil pill showed promise: 79% of men taking it once daily reported visible improvement, versus 35% taking a dummy pill. IFLScience reported on a study involving more than 500 men with Hair Loss. It tested VDPHL01, a pill containing minoxidil, a drug first used for high blood pressure. The company is seeking US approval for its use to grow hair. That makes this news relevant to our Low Dose Oral Minoxidil community, though these results concern the specific pill tested. Men took the pill once daily, twice daily, or took a dummy pill. About 85% in the twice-daily group said they saw visible improvement. A separate question asked how much their hair coverage had improved. Around 56% of the once-daily group reported “improved” or “much improved” coverage. That rose to 69% with twice-daily use, versus 15% with the dummy pill. These figures reflect what men said they noticed. They are not counts of new hairs. The report said the drug was generally well tolerated. No serious side effects were reported, which does not mean there were no side effects. The supplied text does not give doses or study length. It also does not show whether these results apply to women. For members, this offers a useful comparison point—not a promised result. Dated photos and notes about coverage could help put your own changes in context. Recording your dose, months of use, and any side effects can also make community comparisons more useful. The report describes existing oral use for hair growth as outside its approved purpose; seeking approval is not the same as receiving it. What changes have you noticed over time, and how are you tracking them?